SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q2 2021$326,000
-9.4%
49,035
+26.0%
0.01%0.0%
Q1 2021$360,000
-55.7%
38,912
-13.7%
0.01%
-60.0%
Q4 2020$812,000
+47.1%
45,112
+15.9%
0.02%
-6.2%
Q3 2020$552,00038,9120.02%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 120,600$299,0000.32%
Artal Group S.A. 750,000$1,860,0000.08%
Eventide Asset Management 1,467,922$3,640,0000.06%
Atom Investors LP 33,798$84,0000.04%
XTX Topco Ltd 25,154$62,0000.03%
ELKHORN PARTNERS LIMITED PARTNERSHIP 19,000$47,0000.02%
Engineers Gate Manager LP 245,567$609,0000.02%
GSA CAPITAL PARTNERS LLP 63,749$158,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 168,902$419,0000.01%
Walleye Capital LLC 123,305$306,0000.01%
View complete list of CARDIFF ONCOLOGY INC shareholders